Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named Crown Castle Inc. CCI as her final trade.

Crown Castle, last month, announced a comprehensive review of its Fiber business and the addition of two new independent directors to the company's board.

Also Read: 'Business Insider Is Toast:' Bill Ackman Vows To 'Unleash Hell' In Lawsuit Against Media Site Over Plagiarism Claims Against Wife

Joseph Terranova of Virtus Investment Partners picked Marathon Petroleum Corporation MPC, as energy equities last year were one of the leaders

Marathon Petroleum recently named Maryann Mannen as President and John Quaid as Executive Vice President and CFO.

Don’t forget to check out our premarket coverage here

Brenda Vingiello of Sand Hill Global Advisors said Stryker Corporation SYK had a great last year and is poised for another great year.

On Friday, RBC Capital analyst Shagun Singh maintained Stryker with an Outperform rating and raised the price target from $315 to $345.

Jim Lebenthal of Cerity Partners said AbbVie Inc. ABBV has a great valuation and dividend yield.

AbbVie recently announced a strategic collaboration with Umoja Biopharma to develop novel In-Situ CAR-T cell therapies.

Price Action: Crown Castle shares slipped 0.01% to close at $112.71, while Marathon Petroleum gained 1.3% to close at $157.46 on Friday. Stryker gained 1.3% to $312.90, while AbbVie gained by 0.1% to $162.40 during Friday’s session.

Check This Out: Qualcomm, NetApp And 2 Other Stocks Insiders Are Selling

Photo: Shutterstock